A Randomised, Open-label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of AZD1775 After Oral Dosing of a Capsule Formulation in Patients With Advanced Solid Tumours
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2018
At a glance
- Drugs AZD-1775 (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 20 Nov 2017 Planned End Date changed from 20 Mar 2018 to 5 Apr 2018.
- 20 Nov 2017 Planned primary completion date changed from 20 Mar 2018 to 5 Apr 2018.
- 26 Oct 2017 New trial record